Cinclus Pharma’s Q3 2025 presentation focused on the advancement of its lead product, Linaprazan glurate, into Phase 3 clinical trials. The company has successfully initiated the HEEALING-1 study, ...
The following slide provides a visual overview of TED and its effects: Financial Position Viridian reported $563 million in cash as of June 30, 2025, providing runway into the second half of 2027.
Wheeling, Ill. — Slide Products has completed a multi-phase renovation of its headquarters, marking the company's first major overhaul since the early 2000s. The project began with the installation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback